Kidswell Bio Corporation (4584)

Currency in JPY
269.0
+7.0(+2.67%)
Closed·
4584 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 9 days
Fair Value
Day's Range
254.0276.0
52 wk Range
88.0417.0
Key Statistics
Bid/Ask
268.00 / 270.00
Prev. Close
262
Open
260
Day's Range
254-276
52 wk Range
88-417
Volume
1.57M
Average Volume (3m)
4.58M
1-Year Change
92.75%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4584 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
450.0
Upside
+67.29%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Kidswell Bio Corporation Company Profile

Kidswell Bio Corporation develops pharmaceuticals for the treatment of rare and intractable diseases in Japan. Its pipeline products include GND-004 for the treatment of ophthalmic disease and oncology; GND-007 for the treatment of immunological disease; and antibodies for oncology. The company pipeline products also include GBS-001, GBS-004, and GBS-010 for oncology; GBS-005 for immunological diseases; GBS-007 and GBS-012 for ophthalmic disease; GBS-008 for infectious diseases; and GBS-011 for renal disease. In addition, its products also include GCT-101 for alveolar cleft; GCT-102 for congenital isolated hypoganglionosis; and other pipeline products for ophthalmologic diseases, cerebral palsy, peripheral nerve palsy, fracture, and spinal cord injury. The company was formerly known as Gene Techno Science Co.,Ltd. and changed its name to Kidswell Bio Corporation in July 2021. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.

Compare 4584 to Peers and Sector

Metrics to compare
4584
Peers
Sector
Relationship
P/E Ratio
−594.2x−5.5x−0.5x
PEG Ratio
-−0.100.00
Price/Book
8.9x4.2x2.6x
Price / LTM Sales
2.5x48.8x3.3x
Upside (Analyst Target)
71.8%77.6%45.1%
Fair Value Upside
Unlock21.3%7.4%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 450.0
(+67.29% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
4.17 / --
Revenue / Forecast
2.05B / --
EPS Revisions
Last 90 days

4584 Income Statement

People Also Watch

7,430.0
7453
+0.53%
217.0
3936
+1.88%
275.0
3070
+7.42%
987.0
3350
-7.15%
7,700.0
3563
+1.46%

FAQ

What Stock Exchange Does Kidswell Bio Trade On?

Kidswell Bio is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Kidswell Bio?

The stock symbol for Kidswell Bio is "4584."

What Is the Kidswell Bio Market Cap?

As of today, Kidswell Bio market cap is 12.76B.

What Is Kidswell Bio's Earnings Per Share (TTM)?

The Kidswell Bio EPS (TTM) is -0.52.

When Is the Next Kidswell Bio Earnings Date?

Kidswell Bio will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is 4584 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Kidswell Bio Stock Split?

Kidswell Bio has split 2 times.

How Many Employees Does Kidswell Bio Have?

Kidswell Bio has 37 employees.

What is the current trading status of Kidswell Bio (4584)?

As of 04 Aug 2025, Kidswell Bio (4584) is trading at a price of 269.00, with a previous close of 262.00. The stock has fluctuated within a day range of 254.00 to 276.00, while its 52-week range spans from 88.00 to 417.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.